177 related articles for article (PubMed ID: 37251342)
1. Efficacy and safety of antibiotic agents in the treatment of rosacea: a systemic network meta-analysis.
Xiao W; Chen M; Wang B; Huang Y; Zhao Z; Deng Z; Xie H; Li J; Tang Y
Front Pharmacol; 2023; 14():1169916. PubMed ID: 37251342
[No Abstract] [Full Text] [Related]
2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
3. Interventions for rosacea based on the phenotype approach: an updated systematic review including GRADE assessments.
van Zuuren EJ; Fedorowicz Z; Tan J; van der Linden MMD; Arents BWM; Carter B; Charland L
Br J Dermatol; 2019 Jul; 181(1):65-79. PubMed ID: 30585305
[TBL] [Abstract][Full Text] [Related]
4. Interventions for rosacea.
van Zuuren EJ; Kramer S; Carter B; Graber MA; Fedorowicz Z
Cochrane Database Syst Rev; 2011 Mar; (3):CD003262. PubMed ID: 21412882
[TBL] [Abstract][Full Text] [Related]
5. Oral antibiotics for chronic blepharitis.
Onghanseng N; Ng SM; Halim MS; Nguyen QD
Cochrane Database Syst Rev; 2021 Jun; 6(6):CD013697. PubMed ID: 34107053
[TBL] [Abstract][Full Text] [Related]
6. Topical metronidazole maintains remissions of rosacea.
Dahl MV; Katz HI; Krueger GG; Millikan LE; Odom RB; Parker F; Wolf JE; Aly R; Bayles C; Reusser B; Weidner M; Coleman E; Patrignelli R; Tuley MR; Baker MO; Herndon JH; Czernielewski JM
Arch Dermatol; 1998 Jun; 134(6):679-83. PubMed ID: 9645635
[TBL] [Abstract][Full Text] [Related]
7. Interventions for rosacea: abridged updated Cochrane systematic review including GRADE assessments.
van Zuuren EJ; Fedorowicz Z
Br J Dermatol; 2015 Sep; 173(3):651-62. PubMed ID: 26099423
[TBL] [Abstract][Full Text] [Related]
8. Rosacea: An Update in Diagnosis, Classification and Management.
Kang CN; Shah M; Tan J
Skin Therapy Lett; 2021 Jul; 26(4):1-8. PubMed ID: 34347259
[TBL] [Abstract][Full Text] [Related]
9. Maintenance of Remission after Oral Metronidazole Add-on Therapy in Rosacea Treatment: A Retrospective, Comparative Study.
Kim JS; Seo BH; Cha DR; Suh HS; Choi YS
Ann Dermatol; 2022 Dec; 34(6):451-460. PubMed ID: 36478427
[TBL] [Abstract][Full Text] [Related]
10. DOMINO, doxycycline 40 mg vs. minocycline 100 mg in the treatment of rosacea: a randomized, single-blinded, noninferiority trial, comparing efficacy and safety.
van der Linden MMD; van Ratingen AR; van Rappard DC; Nieuwenburg SA; Spuls PI
Br J Dermatol; 2017 Jun; 176(6):1465-1474. PubMed ID: 27797396
[TBL] [Abstract][Full Text] [Related]
11. A Review of the Current Modalities for the Treatment of Papulopustular Rosacea.
McGregor SP; Alinia H; Snyder A; Tuchayi SM; Fleischer A; Feldman SR
Dermatol Clin; 2018 Apr; 36(2):135-150. PubMed ID: 29499797
[TBL] [Abstract][Full Text] [Related]
12. A randomized phase 3b/4 study to evaluate concomitant use of topical ivermectin 1% cream and doxycycline 40-mg modified-release capsules, versus topical ivermectin 1% cream and placebo in the treatment of severe rosacea.
Schaller M; Kemény L; Havlickova B; Jackson JM; Ambroziak M; Lynde C; Gooderham M; Remenyik E; Del Rosso J; Weglowska J; Chavda R; Kerrouche N; Dirschka T; Johnson S
J Am Acad Dermatol; 2020 Feb; 82(2):336-343. PubMed ID: 31150711
[TBL] [Abstract][Full Text] [Related]
13. A Phase II, Randomized, Double-Blind Clinical Study Evaluating the Safety, Tolerability, and Efficacy of a Topical Minocycline Foam, FMX103, for the Treatment of Facial Papulopustular Rosacea.
Mrowietz U; Kedem TH; Keynan R; Eini M; Tamarkin D; Rom D; Shirvan M
Am J Clin Dermatol; 2018 Jun; 19(3):427-436. PubMed ID: 29396702
[TBL] [Abstract][Full Text] [Related]
14. Effective Treatment of Inflammatory Lesions of Rosacea with Subantibiotic Dose Doxycycline Irrespective of Patient Weight or Baseline Lesion Count Severity.
Del Rosso JQ; York JP; Bhatia N
J Clin Aesthet Dermatol; 2022 Nov; 15(11):69-74. PubMed ID: 36381182
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of Treatments in Reducing Inflammatory Lesion Count in Rosacea: A Systematic Review.
Geng RSQ; Sood S; Hua N; Chen J; Sibbald RG; Sibbald C
J Cutan Med Surg; 2024 May; ():12034754241253195. PubMed ID: 38807451
[TBL] [Abstract][Full Text] [Related]
16. A comparison of 15% azelaic acid gel and 0.75% metronidazole gel in the topical treatment of papulopustular rosacea: results of a randomized trial.
Elewski BE; Fleischer AB; Pariser DM
Arch Dermatol; 2003 Nov; 139(11):1444-50. PubMed ID: 14623704
[TBL] [Abstract][Full Text] [Related]
17. Metronidazole gel (0.75%) in Japanese patients with rosacea: A randomized, vehicle-controlled, phase 3 study.
Miyachi Y; Yamasaki K; Fujita T; Fujii C
J Dermatol; 2022 Mar; 49(3):330-340. PubMed ID: 34854112
[TBL] [Abstract][Full Text] [Related]
18. Effective and evidence-based management strategies for rosacea: summary of a Cochrane systematic review.
van Zuuren EJ; Kramer SF; Carter BR; Graber MA; Fedorowicz Z
Br J Dermatol; 2011 Oct; 165(4):760-81. PubMed ID: 21692773
[TBL] [Abstract][Full Text] [Related]
19. Once-daily topical metronidazole cream formulations in the treatment of the papules and pustules of rosacea.
Dahl MV; Jarratt M; Kaplan D; Tuley MR; Baker MD
J Am Acad Dermatol; 2001 Nov; 45(5):723-30. PubMed ID: 11606923
[TBL] [Abstract][Full Text] [Related]
20. Antibiotics for induction and maintenance of remission in Crohn's disease.
Townsend CM; Parker CE; MacDonald JK; Nguyen TM; Jairath V; Feagan BG; Khanna R
Cochrane Database Syst Rev; 2019 Feb; 2(2):CD012730. PubMed ID: 30731030
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
